Response to comment on "Impact of DNA damage repair defects on response to radium-223 and overall survival in metastatic castration-resistant prostate cancer"

Eur J Cancer. 2021 Feb:144:395-396. doi: 10.1016/j.ejca.2020.11.041. Epub 2020 Dec 25.

Authors

Maarten J van der Doelen¹, Peter H J Slootbeek², Niven Mehra³

Affiliations

¹ Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands.
² Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
³ Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: Niven.Mehra@radboudumc.nl.

PMID: 33358841
DOI: 10.1016/j.ejca.2020.11.041

No abstract available

Publication types

Letter
Comment

MeSH terms

DNA Damage
DNA Repair
Humans
Male
Prostatic Neoplasms, Castration-Resistant* / genetics
Prostatic Neoplasms, Castration-Resistant* / radiotherapy
Radium* / therapeutic use

Substances

Radium-223
Radium